Delivery Order SPE2DB22D2007-SPE2DB25FJ4XE
Award Date 9/12/25
Potential Completion Date 10/3/25
Potential Value $9.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $9,266.70 to AmerisourceBergen Drug Corp for the supply of Tavalisse 100 mg tablets (60-count) under a firm fixed-price contract type. The contract, which was competitively awarded with no set-aside designation, is scheduled for completion by August 25, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen Drug Corp's larger...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $9,296.97 to AmerisourceBergen Drug Corp for the supply of Tavalisse 150 mg tablets (60-count) on August 15, 2025, with a completion date of September 8, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The...
- The Defense Logistics Agency awarded a $9,266.70 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Tavalisse 100 mg on August 5, 2025, with completion targeted for August 26, 2025. This competitively awarded, firm fixed price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $9,296.97 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Tavalisse 150 mg, a pharmaceutical product delivered to the company's corporate office location in Conshohocken, Pennsylvania. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026....
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Tavalisse 150 mg tablets (60-count) with a contract ceiling value of $18,593.94. This competitively awarded, non-set-aside delivery order utilizes firm fixed price pricing and is scheduled for completion by October 3, 2025. The order will be fulfilled from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Tavalisse 100 mg tablets (60-count units) with a ceiling value of $18,533.40. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 10, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating it was competed among all eligible...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 10, 2025, for Tavalisse 150 mg tablets (60-count packaging) with a ceiling value of $37,127.34. This competitively awarded, firm fixed-price delivery order is non-set-aside and scheduled for completion by October 1, 2025. The award represents a continuation of the contractor's substantial role in supporting...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Tavalisse 100 mg tablets (60-count units) under a firm fixed-price contract valued at $9,266.70. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The...
- This is a delivery order under a larger contract vehicle awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The delivery order is for $8,549.70 to provide Tavalisse 150 mg tablets. The order has a firm fixed price and a completion date of September 26, 2024. This contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, as well as a...
- The Defense Logistics Agency awarded a delivery order valued at $9,296.97 to AmerisourceBergen Drug Corp for Tavalisse 150 mg tablets (60-count) on September 3, 2025, with completion expected by September 24, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Tavalisse is a prescription medication used to treat immune thrombocytopenia, a bleeding disorder affecting...